Cytoprotective effects of a blue light-filtering intraocular lens on human retinal pigment epithelium by reducing phototoxic effects on vascular endothelial growth factor-α, Bax, and Bcl-2 expression

Journal of Cataract and Refractive Surgery

Volumn 35, Issue 2, 2009, Pages 354-362

  Kernt, Marcus ^a   Neubauer, Aljoscha S ^a   Liegl, Raffael ^a   Eibl, Kirsten H ^a   Alge, Claudia S ^a   Lackerbauer, Carlo A ^a   Ulbig, Michael W ^a   Kampik, Anselm ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PROTEIN BAX; PROTEIN BCL 2; TETRAZOLIUM; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL GROWTH FACTOR ALPHA; VASCULOTROPIN;

ADULT; AGED; ARTICLE; BLUE LIGHT; CELL DAMAGE; CELL DEATH; CELL PROTECTION; CELL STRESS; CELL VIABILITY; COLORIMETRY; FILTRATION; GERMANY; HUMAN; HUMAN CELL; LENS IMPLANT; LIGHT EXPOSURE; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINA INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ULTRAVIOLET RADIATION; WESTERN BLOTTING;

ADULT; AGED; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; CELL SURVIVAL; CELLS, CULTURED; CYTOPROTECTION; GENE EXPRESSION; HUMANS; LENSES, INTRAOCULAR; LIGHT; MICROSCOPY, PHASE-CONTRAST; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-BCL-2; RADIATION PROTECTION; RETINAL PIGMENT EPITHELIUM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; ULTRAVIOLET RAYS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 58649100071     PISSN: 08863350     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcrs.2008.10.052     Document Type: Article

References (58)

1. Ferris III F.L., Fine S.L., and Hyman L. Age-related macular degeneration and blindness due to neovascular maculopathy. Arch Ophthalmol 102 (1984) 1640-1642
2. Witmer A.N., Vrensen G.F.J.M., Van Noorden C., and Schlingemann R.O. Vascular endothelial growth factors and angiogenesis in eye disease. Prog Retin Eye Res 22 (2003) 1-29
3. The Eye Diseases Prevalence Research Group. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol 122 (2004) 477-485
4. Klein R., Klein B.E.K., and Linton K.L. Prevalence of age-related maculopathy; the Beaver Dam Eye Study. Ophthalmology 99 (1992) 933-943
5. The Eye Diseases Prevalence Research Group. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 122 (2004) 564-572
6. Knudtson M.D., Klein R., Klein B.E.K., Lee K.E., Meuer S.M., and Tomany S.C. Location of lesions associated with age-related maculopathy over a 10-year period: the Beaver Dam Eye Study. Invest Ophthalmol Vis Sci 45 (2004) 2135-2142. http://www.iovs.org/cgi/reprint/45/7/2135 Accessed November 4, 2008
7. Darzins P., Mitchell P., and Heller R.F. Sun exposure and age-related macular degeneration; an Australian case-control study. Ophthalmology 104 (1997) 770-776
8. Cruickshanks K.J., Klein R., and Klein B.E.K. Sunlight and age-related macular degeneration; the Beaver Dam Eye Study. Arch Ophthalmol 111 (1993) 514-518
9. Cruickshanks K.J., Klein R., Klein B.E.K., and Nondahl D.M. Sunlight and the 5-year incidence of early age-related maculopathy; the Beaver Dam Eye Study. Arch Ophthalmol 119 (2001) 246-250
10. Tomany S.C., Cruickshanks K.J., Klein R., Klein B.E.K., and Knudtson M.D. Sunlight and the 10-year incidence of age-related maculopathy; the Beaver Dam Eye Study. Arch Ophthalmol 122 (2004) 750-757
11. Norren D.V., and Vos J.J. Spectral transmission of the human ocular media. Vision Res 14 (1974) 1237-1244
12. van den Berg T.J.T.P., and Spekreijse H. Near infrared light absorption in the human eye media. Vision Res 37 (1997) 249-253
13. Bron A.J., Vrensen G.F.J.M., Koretz J., Maraini G., and Harding J.J. The ageing lens. Ophthalmologica 214 (2000) 86-104
14. Mellerio J. Yellowing of the human lens: nuclear and cortical contributions. Vision Res 27 (1987) 1581-1587
15. Weale R.A. Age and the transmittance of the human crystalline lens. J Physiol 95 (1988) 577-587
16. Ham Jr. W.T., Mueller H.A., Ruffolo Jr. J.J., Millen J.E., Cleary S.F., Guerry R.K., and Guerry III D. . Basic mechanisms underlying the production of photochemical lesions in the mammalian retina. Curr Eye Res 3 (1984) 165-174
17. Ham Jr. W.T., Ruffolo Jr. J.J., Mueller H.A., Clarke A.M., and Moon M.E. Histologic analysis of photochemical lesions produced in rhesus retina by short-wavelength light. Invest Ophthalmol Vis Sci 17 (1978) 1029-1035. http://www.iovs.org/cgi/reprint/17/10/1029 Accessed November 4, 2008
18. Mainster M.A., and Sparrow J.R. How much blue light should an IOL transmit?. [perspective]. Br J Ophthalmol 87 (2003) 1523-1529
19. Lawrence H.M., and Reynolds T.R. Erythropsial phototoxicity associated with nonultraviolet-filtering intraocular lenses. J Cataract Refract Surg 15 (1989) 569-572
20. Komatsu M., Kanagami S., and Shimizu K. Ultraviolet-absorbing intraocular lens versus non-UV-absorbing intraocular lens: comparison of angiographic cystoid macular edema. J Cataract Refract Surg 15 (1989) 654-657
21. Braunstein R.E., and Sparrow J.R. A blue-blocking intraocular lens should be used in cataract surgery. [controversies]. Arch Ophthalmol 123 (2005) 547-549
22. Ernest P.H. Light-transmission-spectrum comparison of foldable intraocular lenses. J Cataract Refract Surg 30 (2004) 1755-1758
23. Brockmann C., Schulz M., and Laube T. Transmittance characteristics of ultraviolet and blue-light-filtering intraocular lenses. J Cataract Refract Surg 34 (2008) 1161-1166
24. Algvere P.V., and Seregard S. Age-related maculopathy: pathogenetic features and new treatment modalities. Acta Ophthalmol Scand 80 (2002) 136-143
25. Roth F., Bindewald A., and Holz F.G. Key pathophysiologic pathways in age-related macular disease. Graefes Arch Clin Exp Ophthalmol 242 (2004) 710-716
26. Wing G.L., Blanchard G.C., and Weiter J.J. The topography and age relationship of lipofuscin concentration in the retinal pigment epithelium. Invest Ophthalmol Vis Sci 17 (1978) 601-607. http://www.iovs.org/cgi/reprint/17/7/601 Accessed November 4, 2008
27. Weiter J.J., Delori F.C., Wing G.L., and Fitch K.A. Retinal pigment epithelial lipofuscin and melanin and choroidal melanin in human eyes. Invest Ophthalmol Vis Sci 27 (1986) 145-152. http://www.iovs.org/cgi/reprint/27/2/145 Accessed November 4, 2008
28. Holz F.G., Bellmann C., Margaritidis M., Schütt F., Otto T.P., and Völcker H.E. Patterns of increased in vivo fundus autofluorescence in the junctional zone of geographic atrophy of the retinal pigment epithelium associated with age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 237 (1999) 145-152
29. Sparrow J.R., Miller A.S., and Zhou J. Blue light-absorbing intraocular lens and retinal pigment epithelium protection in vitro. J Cataract Refract Surg 30 (2004) 873-878
30. Yanagi Y., Inoue Y., Iriyama A., and Jang W.-D. Effects of yellow intraocular lenses on light-induced upregulation of vascular endothelial growth factor. J Cataract Refract Surg 32 (2006) 1540-1544
31. Barishak Y.R. In vitro behaviour of the pigmented cells of the retina and uvea of the adult human eye. Acta Ophthalmol (Copenh) 38 (1960) 339-346
32. Flood M.T., Gouras P., and Kjeldbye H. Growth characteristics and ultrastructure of human retinal pigment epithelium in vitro. Invest Ophthalmol Vis Sci 19 (1980) 1309-1320. http://www.iovs.org/cgi/reprint/19/11/1309 Accessed November 4, 2008
33. Nilsson S.E.G., Sundelin S.P., Wihlmark U., and Brunk U.T. Aging of cultured retinal pigment epithelial cells: oxidative reactions, lipofuscin formation and blue light damage. Doc Ophthalmol 106 (2003) 13-16
34. Waisbourd M., Loewenstein A., Goldstein M., and Leibovitch I. Targeting vascular endothelial growth factor; a promising strategy for treating age-related macular degeneration. Drugs Aging 24 (2007) 643-662
35. Kernt M., Neubauer A.S., Ulbig M.W., Kampik A., and Welge-Lüßen U. In vitro safety of intravitreal moxifloxacin for endophthalmitis treatment. J Cataract Refract Surg 34 (2008) 480-488
36. Leschey K.H., Hackett S.F., Singer J.H., and Campochiaro P.A. Growth factor responsiveness of human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 31 (1990) 839-846. http://www.iovs.org/cgi/reprint/31/5/839 Accessed November 4, 2008
37. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65 (1983) 55-63
38. Welge-Lüßen U., May C.A., Eichhorn M., Bloemendal H., and Lütjen-Drecoll E. αB-crystallin in the trabecular meshwork is inducible by transforming growth factor-β. Invest Ophthalmol Vis Sci 40 (1999) 2235-2241. http://www.iovs.org/cgi/reprint/40/10/2235 Accessed November 4, 2008
39. Hawkins B.S., Bird A., Klein R., and West S.K. Epidemiology of age-related macular degeneration. Mol Vis 5 (1999) 26. http://www.molvis.org/molvis/v5/a26/v5a26-hawkins.pdf Accessed November 4 2008
40. Klein R., Klein B.E.K., Jensen S.C., and Meuer S.M. The five-year incidence and progression of age-related maculopathy; the Beaver Dam Eye Study. Ophthalmology 104 (1997) 7-21
41. Algvere P.V., Marshall J., and Seregard S. Age-related maculopathy and the impact of blue light hazard. Acta Ophthalmol Scand 84 (2006) 4-15
42. Katz M.L. Potential role of retinal pigment epithelial lipofuscin accumulation in age-related macular degeneration. Arch Gerontol Geriatr 34 (2002) 359-370
43. Levine A.J. p53, the cellular gatekeeper for growth and division. Cell 88 (1997) 323-331. http://www.elsevier.com/framework_products/Chemistry/p53thecellular.pdf Accessed November 4, 2008
44. McKinnon S.J., Lehman D.M., Kerrigan-Baumrind L.A., Merges C.A., Pease M.E., Kerrigan D.F., Ransom N.L., Tahzib N.G., Reitsamer H.A., Levkovitch-Verbin H., Quigley H.A., and Zack D.J. Caspase activation and amyloid precursor protein cleavage in rat ocular hypertension. Invest Ophthalmol Vis Sci 43 (2002) 1077-1087. http://www.iovs.org/cgi/reprint/43/4/1077 Accessed November 4, 2008
45. Rezai K.A., Gasyna E., Seagle B.-L.L., Norris Jr. J.R., and Rezaei K.A. AcrySof Natural filter decreases blue light-induced apoptosis in human retinal pigment epithelium Graefes Arch Clin Exp. Ophthalmol 246 (2008) 671-676
46. Kluck R.M., Esposti M.D., Perkins G., Renken C., Kuwana T., Bossy-Wetzel E., Goldberg M.G., Allen T., Barber M.J., Green D.R., and Newmeyer D.D. The pro-apoptotic proteins, Bid and Bax, cause a limited permeabilization of the mitochondrial outer membrane that is enhanced by cytosol. J Cell Biol 147 (1999) 809-822. http://jcb.rupress.org/cgi/reprint/147/4/809 Accessed November 4, 2008
47. Esposti M.D., Hatzinisiriou I., McLennan H., and Ralph S. Bcl-2 and mitochondrial oxygen radicals; new approaches with reactive oxygen species-sensitive probes. J Biol Chem 274 (1999) 29831-29837. http://www.jbc.org/cgi/reprint/274/42/29831 Accessed November 4, 2008
48. 2. Exp Eye Res 74 (2002) 663-669
49. Chen J., Flannery J.G., LaVail M.M., Steinberg R.H., Xu J., and Simon M.I. Bcl-2 overexpression reduces apoptotic photoreceptor cell death in three different retinal degenerations. Proc Natl Acad Sci USA 93 (1996) 7042-7047. Available at: http://www.pnas.org/content/93/14/7042.full.pdf+html Accessed November 4, 2008
50. Deng G., Su J.H., Ivins K.J., Van Houten B., and Cotman C.W. Bcl-2 facilitates recovery from DNA damage after oxidative stress. Exp Neurol 159 (1999) 309-318
51. Ryan J.J., Prochownik E., Gottlieb C.A., Apel I.J., Merino R., Nuñez G., and Clarke M.F. C-myc and bcl-2 modulate p53 function by altering p53 subcellular trafficking during the cell cycle. Proc Natl Acad Sci USA 91 (1994) 5878-5882. Available at: http://www.pnas.org/content/91/13/5878.full.pdf+html Accessed November 4, 2008
52. Sparrow J.R., and Cai B. Blue light-induced apoptosis of A2E-containing RPE: involvement of caspase-3 and protection by Bcl-2. Invest Ophthalmol Vis Sci 42 (2001) 1356-1362. http://www.iovs.org/cgi/content/abstract/42/6/1356 Accessed November 4, 2008
53. L/Bax proteins direct the fate of embryonic cortical precursor cells. Mol Cell Biol 27 (2007) 4293-4305. http://mcb.asm.org/cgi/reprint/27/12/4293 Accessed November 4, 2008
54. Liang Y., Jørgensen A., Kæstel C.G., Wiencke A.K., Lui G.M., la Cour M.H., Röpke C.H., and Nissen M.H. . Bcl-2, Bax, and c-Fos expression correlates to RPE cell apoptosis induced by UV-light and daunorubicin. Curr Eye Res 20 (2000) 25-34
55. Lindsten T., Zong W.-X., and Thompson C.B. Defining the role of the Bcl-2 family of proteins in the nervous system. Neuroscientist 11 (2005) 10-15
56. Zhou J., Cai B., Jang Y.P., Pachydaki S., Schmidt A.M., and Sparrow J.R. Mechanisms for the induction of HNE- MDA- and AGE-adducts, RAGE and VEGF in retinal pigment epithelial cells. Exp Eye Res 80 (2005) 567-580
57. Klein R., Klein B.E.K., Wang Q., and Moss S.E. Is age-related maculopathy associated with cataracts?. Arch Ophthalmol 112 (1994) 191-196
58. Wang J.J., Klein R., Smith W., Klein B.E.K., Tomany S., and Mitchell P. Cataract surgery and the 5-year incidence of late-stage age-related maculopathy; pooled findings from the Beaver Dam and Blue Mountains Eye Studies. Ophthalmology 110 (2003) 1960-1967